National Catholic Reporter

The Independent News Source

Cardinal: Obama stem-cell policy ignores ethics

A colony of human embryonic stem cells (light blue)(CNS photo/Alan Trounson, California Institute for Regenerative Medicine via Reuters)

WASHINGTON -- President Barack Obama's executive order reversing the ban on federal funding of embryonic stem-cell research represents "a sad victory of politics over science and ethics," Cardinal Justin Rigali of Philadelphia said shortly after the March 9 signing of the order at the White House.

The chairman of the U.S. Conference of Catholic Bishops' Committee on Pro-Life Activities was among Catholic, pro-life and other leaders who criticized the reversal, which Obama had promised during his campaign.

t(Check back at NCRonline.org today for more reactions.)
t
tSpeaking in the East Room of the White House, Obama said the stem-cell policy of former President George W. Bush, in effect since Aug. 9, 2001, had forced "a false choice between sound science and moral values."
t
tObama also urged Congress to consider further expansion of funding for such research. Since 1995, the Dickey/Wicker amendment to the annual appropriations bills for federal health programs has barred federal funding of research involving the creation or destruction of human embryos.
t
tBut the president had strong words against human cloning, which he said is "dangerous, profoundly wrong and has no place in our society, or any society." He said he would work to ensure that "our government never opens the door to the use of cloning for human reproduction."
t
tAmong the several dozen people present at the White House for the signing were members of Congress, scientists, families whose members had been or could be affected by stem-cell breakthroughs, and representatives of the Episcopal and United Methodist churches, several Jewish bodies and the Interfaith Alliance.
t
tObama said a "majority of Americans -- from across the political spectrum, and of all backgrounds and beliefs -- have come to a consensus that we should pursue" embryonic stem-cell research.
t
tBut Rigali said the executive order "disregards the values of millions of American taxpayers who oppose research that requires taking human life" and "ignores the fact that ethically sound means for advancing stem-cell science and medical treatments are readily available and in need of increased support."
t
tHe reiterated points raised by Cardinal Francis E. George of Chicago, USCCB president, who said in a Jan. 16 letter to Obama that a change in the policy on funding of embryonic stem-cell research "could be a terrible mistake -- morally, politically and in terms of advancing the solidarity and well-being of our nation's people."
t
tObama said he "cannot guarantee that we will find the treatments and cures we seek. No president can promise that."
t
t"But I can promise that we will seek them -- actively, responsibly and with the urgency required to make up for lost ground," he added.
t
tThe Bush policy had allowed funding of embryonic stem-cell research only when the stem-cell line had been created before Aug. 9, 2001. The executive order Obama signed permits federal funding of stem-cell lines created since then, but would not allow funding of the creation of new lines, leaving that decision to Congress.
t
tObama also signed a "presidential memorandum on scientific integrity" March 9, ordering the director of the Office of Science and Technology Policy to develop a strategy for ensuring that "the administration's decisions about public policy be guided by the most accurate and objective scientific advice available."
t
tHe said scientific advisers should be appointed "based on their credentials and experience, not their politics or ideology."
t
tBut Paul A. Long, vice president for public policy at the Michigan Catholic Conference, said the order "regrettably places ideology and political posturing ahead of proven scientific therapeutic advancements."
t
t"There are endless studies and stories of patients who have been treated, even cured of their debilitating condition following stem-cell therapies that do not necessitate the destruction of human embryos, yet the ... executive order makes every tax-paying American citizen unwittingly complicit in the destruction of human embryos for experimental research."

Kristen Day, executive director of Democrats for Life of America, said the president's decision -- which the organization "is against, ... period" -- surprised the group and signaled "a cooling of our relations" with the Obama administration.
t
tRep. Chris Smith, R-N.J., the author of a 2005 law authorizing $265 million in federal research funds for adult stem cells from cord blood and bone marrow, asked in a statement: "Why does the president persist in the dehumanizing of nascent human life when better alternatives exist?"
t
t"On both ethics grounds and efficacy grounds nonembryonic-destroying stem-cell research is the present and future of regenerative medicine -- and the only responsible way forward," Smith added.

Help keep NCR going!
We rely on donations to bring you the latest news.
Donate today.

NCR Comment code: (Comments can be found below)

Before you can post a comment, you must verify your email address at Disqus.com/verify.
Comments from unverified email addresses will be deleted.

  • Be respectful. Do not attack the writer. Take on the idea, not the messenger.
  • Don't use obscene, profane or vulgar language.
  • Stay on point. Comments that stray from the original idea will be deleted. NCR reserves the right to close comment threads when discussions are no longer productive.

We are not able to monitor every comment that comes through. If you see something objectionable, please click the "Report abuse" button. Once a comment has been flagged, an NCR staff member will investigate.

For more detailed guidelines, visit our User Guidelines page.

For help on how to post a comment, visit our reference page.

 

Feature-flag_GSR_start-reading.jpg

NCR Email Alerts

 

In This Issue

August 15-28, 2014

08-15-2014.jpg

Not all of our content is online. Subscribe to receive all the news and features you won't find anywhere else.